Jose Manuel C. M.
- Country
- Spain
- Department
- Pulmonology
Research Overview
- Evaluation of ARO-MMP7 Inhalation Solution in Idiopathic Pulmonary Fibrosis: A Phase 1/2a Clinical Trial in Healthy Subjects and Patients
- A Phase 2a Study to Evaluate the Safety and Efficacy of ABBV-142 in Adults with Idiopathic Pulmonary Fibrosis
- Comparison of Adjuvant Elacestrant with Standard Endocrine Therapy in High-Risk ER+/HER2- Early Breast Cancer
Data & Insights
Has run more than one trial at 189 of 406 partner sites.
Specializations
Pulmonary Arterial Hypertension
This investigator specializes in treating pulmonary arterial hypertension (PAH), conducting research on innovative therapeutic approaches including inhaled treatments and novel pharmaceutical agents. Their work encompasses evaluation of various treatments including seralutinib and sotatercept for PAH management.
- Long-term PAH therapy optimization
- Novel therapeutic interventions
- Treatment of high-risk PAH patients
Pulmonary Fibrosis Research
The investigator focuses on treating various forms of pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). Their research involves evaluating treatments for improving lung function and managing associated symptoms such as chronic cough.
- IPF treatment development
- Progressive fibrosing lung diseases
- Cough management in fibrotic conditions
Specialized Pulmonary Conditions
Research extends to other respiratory conditions including pulmonary sarcoidosis and pulmonary hypertension associated with COPD. The investigator evaluates novel therapeutic approaches for these complex respiratory disorders.
- Interstitial lung diseases
- Sarcoidosis treatment
- COPD-related complications
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.